BACKGROUND AND PURPOSE: A class of drugs known as KATP‐channel openers induce cardioprotection. This study examined the effects of the novel KATP‐channel opener, the fluorine‐containing pinacidil derivative, flocalin, on cardiac‐specific KATP‐channels, excitability of native cardiac myocytes and on the ischaemic heart.EXPERIMENTAL APPROACH: The action of flocalin was investigated on: (i) membrane currents through cardiac‐specific KATP‐channels (IKATP) formed by KIR6.2/SUR2A heterologously expressed in HEK‐293 cells (HEK‐2936.2/2A); (ii) excitability and intracellular Ca2+([Ca2+]i) transients of cultured rat neonatal cardiac myocytes; and (iii) functional and ultrastructural characteristics of isolated guinea‐pig hearts subjected to ischaemia‐reperfusion.KEY RESULTS: Flocalin concentration‐dependently activated a glibenclamide‐sensitive IKATPin HEK‐2936.2/2Acells with an EC50= 8.1 ± 0.4 µM. In cardiac myocytes, flocalin (5 µM) hyperpolarized resting potential by 3–5 mV, markedly shortened action potential duration, reduced the amplitude of [Ca2+]itransients by 2–3‐fold and suppressed contraction. The magnitude and extent of reversibility of these effects depended on the type of cardiac myocytes. In isolated hearts, perfusion with 5 µmol·L−1flocalin, before inducing ischaemia, facilitated restoration of contraction during reperfusion, decreased the number of extrasystoles, prevented the appearance of coronary vasoconstriction and reduced damage to the cardiac tissue at the ultrastructural level (state of myofibrils, membrane integrity, mitochondrial cristae structure).CONCLUSION AND IMPLICATIONS: Flocalin induced potent cardioprotection by activating cardiac‐type KATP‐channels with all the benefits of the presence of fluorine group in the drug structure: higher lipophilicity, decreased toxicity, resistance to oxidation and thermal degradation, decreased metabolism in the organism and prolonged therapeutic action.
Background: The aging process is accompanied by the weakening of the protective systems of the organism, in particular by the decrease in the expression of ATP-sensitive potassium (KATP) channels and in the synthesis of H2S. The aim of our work was to investigate the role of KATP channels in the cardioprotection induced by pyridoxal-5-phosphate (PLP) in aging. Methods: Experiments were performed on adult and old (aged 24 months) male Wistar rats, which were divided into 3 groups: adults, old, and old PLP-treated rats. PLP was administered orally once a day for 14 days at a dose of 0.7 mg/kg. The levels of mRNA expression of subunits KATP channels were determined by reverse transcription and real-time polymerase chain reaction analysis. Protein expression levels were determined by the Western blot. Cardiac tissue morphology was determined using transverse 6 μm deparaffinized sections stained with picrosirius red staining. Vasorelaxation responses of isolated aortic rings and the function of Langendorff-perfused isolated hearts during ischemia-reperfusion, H2S levels, and markers of oxidative stress were also studied. Results: Administration of PLP to old rats reduces cardiac fibrosis and improves cardiac function during ischemia-reperfusion and vasorelaxation responses to KATP channels opening. At the same time, there was a significant increase in mRNA and protein expression of SUR2 and Kir6.1 subunits of KATP channels, H2S production, and reduced markers of oxidative stress. The specific KATP channel inhibitor—glibenclamide prevented the enhancement of vasodilator responses and anti-ischemic protection in PLP-treated animals. Conclusions: We suggest that this potential therapeutic effect of PLP in old animals may be a result of increased expression of KATP channels and H2S production.
8 September 2012 in Naunyn-Schmiedeberg's Archives of Pharmacology
Background. In the present work, we investigated the effect of exogenous glutathione in old rats on the expression of ATP‐sensitive potassium (KATP) channels, the mitochondrial permeability transition pore (mPTP) opening in the heart, and the vasorelaxation responses of isolated aortic rings to activation of KATP channels. Methods. Experiments were performed on adult (6 months) and old (24 months) male Wistar rats, which were divided into three groups: adult, old, and glutathione‐treated old rats. Glutathione was injected intraperitoneally at a dose of 52 mg/kg 1 hour before the studies. The mRNA expression of KATP channels was determined using reverse transcription and real‐time polymerase chain reaction analysis. The effect of glutathione administration on mPTP opening, relaxation responses of isolated aortic rings, and oxidative stress markers was studied. Results. It was shown that the expression levels of Kir6.1, Kir6.2, and SUR1 subunits of KATP channels and levels of reduced glutathione were significantly increased in glutathione‐treated old rats (by 8.3, 2.8, 13.1, and 1.5‐fold, respectively), whereas the levels of oxidative stress markers (hydrogen peroxide, diene conjugates, malondialdehyde, and rate of superoxide generation) in heart mitochondria and mPTP opening were significantly reduced. Relaxation of aortic rings was significantly increased in response to the actions of KATP channel openers flocalin and pinacidil in glutathione‐treated animals, which was prevented by glibenclamide. Conclusions. Thus, the administration of exogenous glutathione to old rats resulted in a significant increase in the expression levels of the Kir6.1, Kir6.2, and SUR1 subunits of KATP channels and a decrease in oxidative stress. This was accompanied by inhibition of mPTP opening and enhancement of vasorelaxation responses to activation of KATP channels.
1 January 2010 in International Journal of Physiology and Pathophysiology
In experiments on the anesthetized dogs with modeling of experimental ischemia (90 min) and reperfusion (180 min), participation of biochemical processes in the cardioprotective effect of the preischemic activation of ATP-sensitive potassium (KATP) channels caused by intravenous introduction of flocalin, a new fluorine-containing opener of these channels was shown. Flocalin was introduced in a dose of 0.1 mg/kg of animal body weight which practically did nit change parameters of hemodynamic under normoxia. Thus, experiments on the influence of flocalin on changes of biochemical parameters of arterial blood during ischemia-reperfusion of myocardium revealed certain features of ischemia-reperfusion syndrome development under stimulation of KATP channels. Analysis of blood biochemical parameters revealed that flocalin suppressed free radicals reactions and manifested anti-oxidative properties: reduced quantity of H2O2 and NO3- (the latter can be interpreted as a reduction in peroxini-trite formation), prevented the decline of catalase and superoxide dismutase activity. Practically constant content of low-molecular nitrosothiols in blood during the whole experiment and increase in the level of NO2- during the reperfusion can be indicative of intact functions of the NO system and protective influence of flocalin during the ischemia-reperfusion of myocardium. Practically the unchanged content of inorganic phosphorus and uric acid in blood during ischemia-reperfusion under conditions of preischemic introduction of flocalin indicates that there is a prevention of ATP degradation and formation of both superoxide anion by xantinoxidase and peroxinitrite by its interaction with nitric oxide. All the mentioned properties of flocalin, related with the changes in biochemical parameters of arterial blood, together with the changes in hemodynamic parameters, result in decrease of infarct size in myocardium after ischemia-reperfusion by 37% versus control experiments.